Physician
Hematology
Dr. Kevin P. Ridenhour, MD
Dr. Kevin P. Ridenhour is an expert in the field of Hematology. He researched medicine at Brody School of Medicine at East Carolina University. He has 1 awards "CMS Meaningful Use Stage 1 Certification". Kevin Ridenhour is a published doctor and has 1 publication published. The lastest was: 'Phase II trial of combination interferon-alpha and thalidomide as first-line therapy in metastatic renal cell carcinoma.' He accepts all Medicare patients.
Publications
Schools
East Carolina University
Wake Forest University
Procedures Preformed
Conditions Treated
- Acute Leukemia
- Anal and Rectal Cancer
- Anemia
- Antiphospholipid Syndrome (APS)
- View All
Doctors Specialties
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Wake Forest University
-
Brody School of Medicine at East Carolina University
Drug Facts
NPI NUMBER |
|
1568462059 |
NPPES Provider LastName |
|
RIDENHOUR |
NPPES Provider FirstName |
|
KEVIN |
NPPES Provider ZIPCode |
|
423030839 |
NPPES Provider State |
|
KY |
Specialty Description |
|
Hematology/Oncology |
Total Claim Count |
|
729.0 |
Distinct Opioid Count |
|
4.0 |
Opioid Claim Count |
|
111.0 |
Percent Opioid Claims |
|
15.23 |
Helpful Reviews
Give
Anonymous Review
Medicare Facts
National Provider Identifier [NPI] |
1568462059 |
Last Name Of The Provider |
RIDENHOUR |
First Name Of The Provider |
KEVIN |
View All |
|
Similar Doctors
Doctor Directory | TOS | twitter | FB | Angel | blog